HomeCompareRPGLF vs JEPQ

RPGLF vs JEPQ: Dividend Comparison 2026

RPGLF yields 33898.31% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPGLF wins by $9.963396520724352e+21M in total portfolio value
10 years
RPGLF
RPGLF
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full RPGLF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — RPGLF vs JEPQ

📍 RPGLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPGLFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPGLF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPGLF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPGLF
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, RPGLF beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPGLF + JEPQ for your $10,000?

RPGLF: 50%JEPQ: 50%
100% JEPQ50/50100% RPGLF
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPGLF buys
0
JEPQ buys
0
No recent congressional trades found for RPGLF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPGLFJEPQ
Forward yield33898.31%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$9.963396520724352e+21M$44.8K
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00$2,152.59
Total dividends collected$9.959616773768018e+21M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RPGLF vs JEPQ ($10,000, DRIP)

YearRPGLF PortfolioRPGLF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$3,400,531$3,389,830.51$11,930$1,110.39+$3.39MRPGLF
2$1,080,949,041$1,077,310,473.14$14,133$1,224.34+$1080.93MRPGLF
3$321,205,007,173$320,048,391,699.27$16,632$1,340.46+$321204.99MRPGLF
4$89,224,694,578,678$88,881,005,221,002.70$19,454$1,457.97+$89224694.56MRPGLF
5$23,169,738,996,241,900$23,074,268,573,042,710.00$22,626$1,576.08+$23169738996.22MRPGLF
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$26,175$1,694.09+$5624691175493.50MRPGLF
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$30,133$1,811.32+$1276516462323700.25MRPGLF
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$34,531$1,927.17+$270840549707403520.00MRPGLF
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$39,403$2,041.08+$53724262376359346176.00MRPGLF
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$44,787$2,152.59+$9.963396520724352e+21MRPGLF

RPGLF vs JEPQ: Complete Analysis 2026

RPGLFStock

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.

Full RPGLF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this RPGLF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPGLF vs SCHDRPGLF vs JEPIRPGLF vs ORPGLF vs KORPGLF vs MAINRPGLF vs XYLDRPGLF vs QYLDRPGLF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.